Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2020-06-01 Interim / Quarterly Rep…
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis – Quarterly Highlights' for the three months ended March 31, 2020. It contains detailed discussion of the company's financial condition, operational results, business environment impacts (such as COVID-19), new orders, strategic holdings, stock exchange listing updates, technology validation, and product information. The document explicitly states it is a Management Discussion and Analysis (MD&A) and references unaudited condensed consolidated interim financial statements for the quarter. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. This matches the definition of an Interim / Quarterly Report (IR), which includes substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, the correct classification is IR with high confidence. Q1 2020
2020-06-01 English
News release - English.pdf
Regulatory Filings
2020-06-01 English
News release - English.pdf
Regulatory Filings
2020-05-22 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a brokered private placement of flow-through shares and the exercise of agents' options related to a previously announced brokered unit financing. It details the terms of the financing, use of proceeds, fees, and legal disclaimers. There are no financial statements, quarterly or annual results, or management discussion of financial performance. The content focuses on capital raising activities and financing terms. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing, not just an announcement of a report or a brief notice.
2020-05-04 English
Annual MD&A - English.pdf
Regulatory Filings
2020-04-30 English
Audited annual financial statements – English.pdf
Regulatory Filings
2020-04-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.